The PurpleLab^® Resource Center

Biomarker testing guides selection of targeted therapies in non–small cell lung cancer (NSCLC). Despite its clinical importance, the extent of provider variation in biomarker testing practices and its correlation with patient outcomes has not been thoroughly explored.

The collaboration extends PurpleLab®’s healthcare audience reach through Comscore’s AI predictive technology.   PurpleLab, a healthcare analytics company powering evidence-based decisions across life sciences, is now part of Comscore’s AI-powered Data Partner Network. The initiative enables data providers like PurpleLab to transform ID-based datasets into scalable, privacy-centric audiences using Proximic by Comscore’s proprietary AI predictive…

PurpleLab®, a healthcare analytics company specializing in real-world data, announced it has acquired KAID Health, an AI-powered clinical analytics and care management company. The combination brings together PurpleLab’s large-scale structured claims data with KAID Health’s artificial intelligence and natural language processing technology, creating a more complete view of patient journeys across structured and unstructured data…